Skip to main navigation
Toggle navigation
REGENXBIO_Logo-RGB
REGENXBIO_Logo-RGB
Corporate Menu
About
Mission & Values
Management Team
Board of Directors
Nav Technology
Therapeutic Programs
RGX-314
RGX-202
RGX-121
RGX-111
RGX-181
RGX-381
Patients and Families
Gene Therapy
Wet AMD
Duchenne
MPS II
MPS I
CLN2
Expanded Access
Partners & Licensees
Partners & Licensees Pipeline
Media
Press Releases
Presentations & Publications
Investors
Stock Information
Recent News
SEC Filings
Corporate Governance
Shareholder Services
Join Us
Investors
Events
Investor Relations
Stock Information
News & Events
SEC Filings
Corporate Governance
Shareholder Services
Investor Relations
Overview
Stock Information
News & Events
SEC Filings
Corporate Governance
Shareholder Services
Events
Q1 2022 REGENXBIO Inc. Earnings Conference Call
May 4, 2022 | 4:30 PM EDT
Click here for webcast
